Cosme Farma Of India Sells 60 Drugs, Distribution Net To Adcock Ingram
This article was originally published in PharmAsia News
India's Cosme Farma plans to sell 60 of its drugs and a distribution network to South Africa's Adcock Ingram for $86 million.
You may also be interested in...
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”
The Onyx One Clear study, evaluating the Resolute Onyx drug-eluting stent in high bleeding risk patients, met its primary endpoint at the one-year follow up.